About 1,470,000 results
Open links in new tab
  1. Eli (2019 film) - Wikipedia

    Eli is a 2019 American supernatural horror film directed by Ciarán Foy from a screenplay by David Chirchirillo, Ian Goldberg, and Richard Naing, based on a story by Chirchirillo.

  2. Eli (2019) - IMDb

    Eli: Directed by Ciarán Foy. With Charlie Shotwell, Kelly Reilly, Max Martini, Lili Taylor. A boy receiving treatment for his auto-immune disorder discovers that the house he's living in isn't as …

  3. Watch Eli | Netflix Official Site

    Endless entertainment starting at $7.99 Email address Endless entertainment starting at $7.99 Eli

  4. Eli | Official Trailer | Netflix - YouTube

    As a last resort to cure their son’s auto-immune disorder, the Millers move into a sterile manor during his treatments. Eli is tormented by terrifying vision...

  5. Eli (2019) | Rotten Tomatoes

    Discover reviews, ratings, and trailers for Eli (2019) on Rotten Tomatoes. Stay updated with critic and audience scores today!

  6. Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn

    2 days ago · Eli Lilly has agreed to acquire autoimmune oral drug developer Ventyx Biosciences, representing the big pharma company’s latest push to diversify its pipeline beyond blockbuster …

  7. Eli streaming: where to watch movie online? - JustWatch

    Find out how and where to watch "Eli" online on Netflix, Prime Video, and Disney+ today – including 4K and free options.

  8. Eli Savit for Attorney General

    Eli Savit is running for Michigan Attorney General to fight for justice, protect our rights, and stand up to corporate power for all Michiganders.

  9. Schrodinger to offer Eli Lilly's AI drug discovery platform on its ...

    1 day ago · Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.

  10. Eli Lilly Snags Ventyx In $1.2 Billion Deal, But These Other Biotechs ...

    3 days ago · Eli Lilly's plan to buy Ventyx for $1.2 billion benefits more than the takeover target, an analyst said Thursday.